X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (632) 632
Publication (29) 29
Patent (10) 10
Magazine Article (2) 2
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (210) 210
female (201) 201
oncology (201) 201
breast cancer (178) 178
index medicus (158) 158
middle aged (132) 132
cancer (100) 100
adult (98) 98
breast neoplasms - pathology (93) 93
aged (81) 81
chemotherapy (76) 76
breast neoplasms - drug therapy (72) 72
hematology, oncology and palliative medicine (53) 53
breast neoplasms - genetics (50) 50
chemotherapy, adjuvant (44) 44
prognosis (41) 41
women (39) 39
breast neoplasms - mortality (38) 38
care and treatment (38) 38
breast neoplasms - surgery (36) 36
survival (36) 36
breast neoplasms - diagnosis (35) 35
treatment outcome (35) 35
tumors (35) 35
carcinoma (34) 34
retrospective studies (33) 33
metastasis (31) 31
disease-free survival (30) 30
therapy (29) 29
risk (28) 28
analysis (27) 27
research (27) 27
surgery (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
risk factors (26) 26
breast (25) 25
breast neoplasms - metabolism (24) 24
breast neoplasms - therapy (24) 24
cancer patients (24) 24
receptor, erbb-2 - metabolism (24) 24
trastuzumab (24) 24
aged, 80 and over (23) 23
clinical trials (23) 23
follow-up studies (23) 23
mammography (23) 23
diagnosis (22) 22
health aspects (22) 22
neoadjuvant chemotherapy (22) 22
neoadjuvant therapy (22) 22
neoplasm staging (22) 22
obstetrics & gynecology (22) 22
patients (22) 22
mastectomy (21) 21
radiology, nuclear medicine & medical imaging (21) 21
cancer therapies (20) 20
medicine & public health (20) 20
time factors (20) 20
antineoplastic agents - therapeutic use (19) 19
prospective studies (19) 19
radiotherapy (19) 19
young adult (19) 19
breast neoplasms (18) 18
erbb-2 protein (18) 18
neoplasm metastasis (18) 18
paclitaxel (18) 18
survival analysis (18) 18
metastases (17) 17
mutation (17) 17
risk assessment (17) 17
follow-up (16) 16
gene expression profiling (16) 16
kaplan-meier estimate (16) 16
tamoxifen (16) 16
adjuvant treatment (15) 15
breast neoplasms - radiotherapy (15) 15
expression (15) 15
france (15) 15
genetic aspects (15) 15
life sciences (15) 15
brca1 (14) 14
chemistry (14) 14
endocrine therapy (14) 14
pathology (14) 14
biopsy (13) 13
gene expression (13) 13
immunohistochemistry (13) 13
male (13) 13
medical research (13) 13
postmenopausal women (13) 13
predictive value of tests (13) 13
proportional hazards models (13) 13
recurrence (13) 13
studies (13) 13
breast - pathology (12) 12
breast neoplasms - diagnostic imaging (12) 12
combined modality therapy (12) 12
drug therapy (12) 12
her2 (12) 12
multivariate analysis (12) 12
randomized-trial (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 6, pp. 523 - 533
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
Journal Article
BULLETIN DU CANCER, ISSN 0007-4551, 06/2016, Volume 103, Issue 6, pp. S90 - S91
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 2016, Volume 103, Issue 6, pp. S90 - S91
Journal Article
NATURE MEDICINE, ISSN 1078-8956, 11/2014, Volume 20, Issue 11, pp. 1301 - 1309
Some of the anti-neoplastic effects of anthracyclines in mice originate from the induction of innate and T cell-mediated anticancer immune responses. Here we... 
MEDICINE, RESEARCH & EXPERIMENTAL | DOUBLE-STRANDED-RNA | DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNATE | RIG-I | TUMORS | CELL BIOLOGY | TOLL-LIKE RECEPTOR-3 | BREAST-CANCER | ANTICANCER CHEMOTHERAPY | GENE | IMMUNE-RESPONSES | Doxorubicin - therapeutic use | Breast Neoplasms - immunology | Humans | RNA, Messenger - metabolism | Adaptor Proteins, Vesicular Transport - metabolism | Interferon Type I - biosynthesis | Receptors, Pattern Recognition - metabolism | Neoplasm Metastasis | Anthracyclines - pharmacology | Interferon Type I - metabolism | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | RNA - metabolism | Receptor, Interferon alpha-beta - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Treatment Outcome | Toll-Like Receptor 3 - metabolism | Breast Neoplasms - drug therapy | Animals | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Immunocompetence - drug effects | Anthracyclines - therapeutic use | Chemokine CXCL10 - metabolism | Myxovirus Resistance Proteins - metabolism | Doxorubicin - pharmacology | Anthracyclines | Care and treatment | Analysis | Physiological aspects | Interferon | Research | Cancer | Signal transduction | Chemotherapy | Breast cancer | Chemokines | Life Sciences | Immunology | Immunotherapy
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 4, pp. 445 - 452
Objectives This study sought to investigate long-term cardiovascular mortality and its relationship to the use of radiotherapy for breast cancer. Background... 
Cardiovascular | Internal Medicine | causes of death | long-term mortality | long-term risk | radiotherapy | breast cancer | cardiac disease | cardiovascular diseases | International Classification of Diseases | ICD | Institut Gustave Roussy | IGR | internal mammary chain | IMC | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | RISK | CARDIAC MORTALITY | RADIATION-THERAPY | LUNG-CANCER | HEART-DISEASE | MORBIDITY | ADJUVANT RADIOTHERAPY | IONIZING-RADIATION | SURVIVORS | Follow-Up Studies | Radiation Injuries - mortality | Humans | Middle Aged | Cause of Death | Time Factors | Heart - radiation effects | Cardiovascular Diseases - mortality | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | France | Radiotherapy, Adjuvant | Mastectomy, Segmental - methods | Radiotherapy Dosage | Cardiovascular Diseases - etiology | Risk Assessment | Cancer Care Facilities | Breast Neoplasms - drug therapy | Breast Neoplasms - radiotherapy | Survival Analysis | Breast Neoplasms - mortality | Aged | Cohort Studies | Breast cancer | Radiotherapy | Health aspects | Epidemiology | Mortality | Heart | Medical records | Cardiovascular disease | Statistical methods | Histology | Radiation therapy | Multivariate analysis | Cancer therapies | Patients | Survival analysis | Womens health | Surgery | Medical prognosis | Age
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2010, Volume 28, Issue 27, pp. 4111 - 4119
Journal Article